Skip to main content
VCbacked
Log inGet Started

MEDFAR Clinical Solutions

Montreal, Canada

MEDFAR Clinical Solutions provides MYLE, an electronic medical records web application for medical teams.

$22.4M raised
Apr 2023
Series C
Health CareMedicalSoftware

Top Investors

Investissement QuebecFondactionAnges QuebecWalter Capital PartnersEnzo Blasi

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MEDFAR Clinical Solutions

How much funding has MEDFAR Clinical Solutions raised?
MEDFAR Clinical Solutions has raised $22.4M in total funding. The most recent round was Series C. The last funding was announced in April 2023.
Who are MEDFAR Clinical Solutions's investors?
MEDFAR Clinical Solutions's investors include Investissement Quebec, Fondaction, Anges Quebec, Walter Capital Partners, Enzo Blasi.
Where is MEDFAR Clinical Solutions headquartered?
MEDFAR Clinical Solutions is headquartered in Montreal, Canada.
What does MEDFAR Clinical Solutions do?
MEDFAR Clinical Solutions provides MYLE, an electronic medical records web application for medical teams.
What stage is MEDFAR Clinical Solutions at?
MEDFAR Clinical Solutions is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"MEDFAR Clinical Solutions — Funding & Investors." VCBacked, April 18, 2023, https://www.vcbacked.co/company/medfar-clinical-solutions. Accessed June 17, 2026.
APA
VCBacked. (2023). MEDFAR Clinical Solutions — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/medfar-clinical-solutions
Wikipedia (cite web)
{{cite web |title=MEDFAR Clinical Solutions — Funding & Investors |url=https://www.vcbacked.co/company/medfar-clinical-solutions |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K